Red Meat Intake Linked to Increased Risk for Type 2 Diabetes
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Oct. 20, 2023 -- Intake of red meat is associated with an increased risk for type 2 diabetes (T2D), according to a study published online Oct. 19 in the American Journal of Clinical Nutrition.
Xiao Gu, Ph.D., from the Harvard T. H. Chan School of Public Health in Boston, and colleagues examined the associations of intake of red meat with the risk for T2D in a study involving 216,695 participants from the Nurses' Health Study (NHS), NHS II, and Health Professionals Follow-up Study. Semiquantitative food frequency questionnaires were used to assess red meat intake every two to four years.
The researchers documented 22,761 T2D cases over 5,483,981 person-years of follow-up. Positive and approximately linear associations were seen for intakes of total, processed, and unprocessed red meat with higher risks for T2D. Hazard ratios were 1.62, 1.51, and 1.40 for the highest versus the lowest quintiles of total red meat, processed red meat, and unprocessed red meat, respectively. Substitution of one serving/day of nuts and legumes for total, processed, and unprocessed red meat was associated with a lower risk for T2D (hazard ratios, 0.70, 0.59, and 0.71, respectively). A significantly lower risk for T2D was also seen in association with substitution of one serving/day of dairy for total, processed, or unprocessed red meat. After calibration of dietary intakes assessed by weighted diet records, the observed associations became stronger.
"Our findings strongly support dietary guidelines that recommend limiting the consumption of red meat, and this applies to both processed and unprocessed red meat," Gu said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
ENDO: Cardiovascular Events Occur Less Often With GLP1-RA, SGLT-2i for T2D, Liver Disease
FRIDAY, June 7, 2024 -- For adults with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), glucagon-like peptide 1 receptor agonists...
Diabetes Tied to Higher Prevalence of Overactive Bladder
TUESDAY, June 4, 2024 -- Markers of diabetes are positively associated with overactive bladder (OAB), according to a study published online April 28 in Frontiers in...
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.